Videos
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
2
EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
Laura Bukavina, MD, discusses debate on high-grade tumor risk stratification
5
